Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
May 11, 2025
 · 
Reactions
A MyMyelomaTeam Member

Is there a study on how to change our DNA so we don’t have a production of inflowing mm cells in our new blood coming into our bodies?

May 11, 2025
A MyMyelomaTeam Member

It an interesting idea. Researchers have used CRISPR, a gene editing treatment, to cure sickle cell anemia in people after only one treatment. The only problem is cost. Each treatment costs between $2-3 million dollars. I can’t see insurance companies or Medicare paying for this treatment until the costs come way down.

May 11, 2025
A MyMyelomaTeam Member

Our DNA is designed to tell rest of body what to do
DNA, or deoxyribonucleic acid, carries the genetic instructions that determine an organism's development, growth, and function. It's essentially the blueprint for building and operating an organism, containing the information needed to produce proteins, the workhorses of the body.
Here's a more detailed look:
Genetic Information Storage:
DNA stores the genetic information that is passed down from one generation to the next.
Protein Synthesis:
DNA contains the instructions for making proteins, which are essential for various cellular processes.
Cellular Function:
DNA plays a crucial role in controlling cell growth, division, and other functions.
Organism Development:
DNA provides the instructions for an organism's development, from a single cell to a fully formed individual.

It just seems we are fighting a losing battle if all our new blood is coming in from a bad blueprint in our DNA designed to control all the rest of our bodily functions.

We are treating output when we should be treating original input.

May 11, 2025
MyMyelomaTeam

Both genetic and cellular approaches show promise in treating multiple myeloma. Gene therapy is an emerging treatment that works at the DNA level by genetically modifying a patient's own immune cells (T-cells) to better fight the cancer. This approach has shown impressive results in early trials, with many patients Show Full Answer

Both genetic and cellular approaches show promise in treating multiple myeloma. Gene therapy is an emerging treatment that works at the DNA level by genetically modifying a patient's own immune cells (T-cells) to better fight the cancer. This approach has shown impressive results in early trials, with many patients achieving remission or significant reduction in cancer cells. The cellular approach, like stem cell transplantation, works by replacing damaged blood cells with healthy ones and can allow for more aggressive cancer treatments. This established treatment method has the added benefit that donor cells may be better at attacking cancer cells than a patient's own immune system.

Both approaches have their merits, and treatment decisions should be made in consultation with your healthcare team based on your specific situation, disease stage, and eligibility for different treatment options.

May 11, 2025
A MyMyelomaTeam Member

Agree, if you can get in a study, the costs are minimal

May 11, 2025

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Lake Charles, LA

A MyMyelomaTeam Member asked a question 💭
Quincy, IL